Free Trial
NASDAQ:PCSA

Heatwurx (PCSA) Stock Price, News & Analysis

Heatwurx logo
$0.22 +0.01 (+5.60%)
Closing price 04:00 PM Eastern
Extended Trading
$0.21 0.00 (-1.80%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Heatwurx Stock (NASDAQ:PCSA)

Key Stats

Today's Range
$0.20
$0.22
50-Day Range
$0.19
$0.40
52-Week Range
$0.15
$3.10
Volume
2.09 million shs
Average Volume
5.34 million shs
Market Capitalization
$2.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Buy

Company Overview

Heatwurx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

PCSA MarketRank™: 

Heatwurx scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Heatwurx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Heatwurx has only been the subject of 1 research reports in the past 90 days.

  • Read more about Heatwurx's stock forecast and price target.
  • Earnings Growth

    Earnings for Heatwurx are expected to grow in the coming year, from ($4.05) to ($2.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Heatwurx is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Heatwurx is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Heatwurx has a P/B Ratio of 0.47. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Heatwurx's valuation and earnings.
  • Percentage of Shares Shorted

    8.01% of the float of Heatwurx has been sold short.
  • Short Interest Ratio / Days to Cover

    Heatwurx has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Heatwurx has recently increased by 62.76%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Heatwurx does not currently pay a dividend.

  • Dividend Growth

    Heatwurx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.01% of the float of Heatwurx has been sold short.
  • Short Interest Ratio / Days to Cover

    Heatwurx has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Heatwurx has recently increased by 62.76%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Heatwurx has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Heatwurx this week, compared to 0 articles on an average week.
  • Search Interest

    9 people have searched for PCSA on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Heatwurx insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.60% of the stock of Heatwurx is held by insiders.

  • Percentage Held by Institutions

    91.93% of the stock of Heatwurx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Heatwurx's insider trading history.
Receive PCSA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heatwurx and its competitors with MarketBeat's FREE daily newsletter.

PCSA Stock News Headlines

Processa Pares Gains on Equity Offer News
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

PCSA Stock Analysis - Frequently Asked Questions

Heatwurx's stock was trading at $0.8838 on January 1st, 2025. Since then, PCSA shares have decreased by 75.5% and is now trading at $0.2169.

Heatwurx Inc. (NASDAQ:PCSA) announced its earnings results on Thursday, May, 8th. The company reported ($0.30) EPS for the quarter, beating the consensus estimate of ($0.77) by $0.47.

Heatwurx's stock reverse split on the morning of Monday, January 22nd 2024.The 1-20 reverse split was announced on Monday, January 22nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PCSA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Heatwurx investors own include NVIDIA (NVDA), CymaBay Therapeutics (CBAY), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL) and Builders FirstSource (BLDR).

Company Calendar

Last Earnings
5/08/2025
Today
7/16/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PCSA
CIK
1533743
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$2.00
Potential Upside/Downside
+822.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.85 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-319.56%
Return on Assets
-232.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.93
Quick Ratio
2.93

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.46 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
11,884,000
Free Float
10,743,000
Market Cap
$2.58 million
Optionable
Not Optionable
Beta
1.30
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PCSA) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners